TRI Grant Schemes

TRI offers two grant schemes to support translational research projects based at TRI: Spore and Drive.


Spore Grants

The TRI Spore Grants support multidisciplinary teams of scientists and clinicians from a combination of academic, commercial and clinical backgrounds to test innovative ideas. 

These Grants fund projects for up to 12 months, up to a possible total of $90,000 per Grant. 

Four TRI Spore Grants are available in 2019.

Interested in applying for the 2019 round?

Applications open on 29 March 2019, and close on Tuesday 30 April 2019.

Find out more about how to apply.

So far, TRI has awarded eight Spore Grants to support researchers at TRI to progress their research (see 2016 winners and 2018 winners). 

Drive Grants

The TRI Drive Grant is an initiative of TRI which aims to accelerate translation of innovations into the clinic, bringing together multidisciplinary teams of scientists, clinicians and commercial partners to address an unmet clinical need. 

This Grant will support research projects that are beyond proof-of-concept stage, address an important clinical question, and have a defined translational outcome. Areas of interest can include, but are not limited to, research addressing new therapeutics, diagnostics, medical devices, digital health, new clinical intervention programs and repurposing of new drugs. 

A Drive Grant can be up to a possible total of $500,000 over 3 years. 

This first Drive Grant will be available in 2019.

Interested in applying?

Applications open on 29 March 2019, and close on Tuesday 30 April 2019. 

Find out more about how to apply.